2017
DOI: 10.1002/ccr3.1198
|View full text |Cite
|
Sign up to set email alerts
|

Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge

Abstract: Key Clinical MessageA negative flecainide challenge does not rule out Brugada syndrome even in the presence of nonfatal cardiac arrest as the first manifestation of the disease. This should prompt clinicians to ensure long‐term ECG follow‐up and consider repeating a drug test with another sodium channel blocker.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…[13][14][15] Provocative testing can be helpful to identify patients; however, limitations exist as nearly 25% of drug-induced tests might be false negatives. [16][17][18] Further, the "provoked phenotype" might be somewhat of a misnomer especially from the standpoint of risk stratification as many of these patients develop a spontaneous type 1 pattern during follow-up.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[13][14][15] Provocative testing can be helpful to identify patients; however, limitations exist as nearly 25% of drug-induced tests might be false negatives. [16][17][18] Further, the "provoked phenotype" might be somewhat of a misnomer especially from the standpoint of risk stratification as many of these patients develop a spontaneous type 1 pattern during follow-up.…”
Section: Discussionmentioning
confidence: 99%
“… 13 , 14 , 15 Provocative testing can be helpful to identify patients; however, limitations exist, as nearly 25% of drug-induced tests might be false-negatives. 16 , 17 , 18 Further, the “provoked phenotype” might be somewhat of a misnomer, especially from the standpoint of risk stratification, as many of these patients develop a spontaneous type 1 pattern during follow-up. Over the course of our follow-up period, we identified a higher rate of spontaneous type 1 ECG findings than a prior Holter monitoring study that analyzed ECG changes over a significantly shorter duration.…”
Section: Discussionmentioning
confidence: 99%
“… 11 Channelopathies, which typically present in younger patients, are essential to recognize as they carry a risk of sudden death. 12 , 13 Among these patients, arrhythmic syncope is relatively rare 14 , 15 with other more benign aetiological forms being more common, nevertheless still presenting diagnostic difficulties.…”
Section: Introductionmentioning
confidence: 99%